REGENERON PHARMACEUTICALS, INC. Stock Issued During Period, Shares, New Issues
New shares the company issued (share-based compensation, option exercises, employee stock purchase plans, new issues, acquisitions), as filed in its 10-Q and 10-K XBRL statement of shareholders' equity. This is the dilution side; Issuer Repurchases is the other side.
- REGENERON PHARMACEUTICALS, INC. stock issued during period, shares, new issues for the quarter ending 2016-12-31 was 2.24K shares, a 98.91% decline year-over-year.
- REGENERON PHARMACEUTICALS, INC. stock issued during period, shares, new issues for the quarter ending 2016-09-30 was 0.00 shares, a 100.00% decline year-over-year.
- REGENERON PHARMACEUTICALS, INC. stock issued during period, shares, new issues for the quarter ending 2016-06-30 was 102.05K shares, a 91.85% decline year-over-year.
- REGENERON PHARMACEUTICALS, INC. stock issued during period, shares, new issues for the quarter ending 2016-03-31 was 16.77K shares, a 88.53% decline year-over-year.
- REGENERON PHARMACEUTICALS, INC. stock issued during period, shares, new issues for fiscal 2016 was 121.06K shares, a 92.55% decline from fiscal 2015.
- REGENERON PHARMACEUTICALS, INC. stock issued during period, shares, new issues for fiscal 2015 was 1.63M shares, a 19.46% decline from fiscal 2014.
- REGENERON PHARMACEUTICALS, INC. stock issued during period, shares, new issues for fiscal 2014 was 2.02M shares.
| Period end | Stock Issued During Period, Shares, New Issues 3 month | Stock Issued During Period, Shares, New Issues 12 month |
|---|---|---|
| 2016-12-31 | 2.24K shares derived: 10-K 12 month − 10-Q 9 month · filed 2018-02-08 | 121.06K shares 10-K · filed 2018-02-08 |
| 2016-09-30 | 0.00 shares derived: 10-Q 9 month − 10-Q 6 month · filed 2016-11-04 | 324.65K shares derived: sum of 4 quarters · filed 2018-02-08 |
| 2016-06-30 | 102.05K shares derived: 10-Q 6 month − 10-Q 3 month · filed 2016-08-04 | 344.87K shares derived: sum of 4 quarters · filed 2018-02-08 |
| 2016-03-31 | 16.77K shares 10-Q · filed 2017-05-04 | 1.50M shares derived: sum of 4 quarters · filed 2018-02-08 |
| 2015-12-31 | 205.83K shares derived: 10-K 12 month − 10-Q 9 month · filed 2018-02-08 | 1.63M shares 10-K · filed 2018-02-08 |
| 2015-09-30 | 20.22K shares derived: 10-Q 9 month − 10-Q 6 month · filed 2016-11-04 | |
| 2015-06-30 | 1.25M shares derived: 10-Q 6 month − 10-Q 3 month · filed 2016-08-04 | |
| 2015-03-31 | 146.25K shares 10-Q · filed 2016-05-05 | |
| 2014-12-31 | 2.02M shares 10-K · filed 2016-02-11 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| ALNYLAM PHARMACEUTICALS, INC. (ALNY) | United States | $33.420B | 54.94 |
| Zoetis Inc. (ZTS) | United States | $29.045B | 11.38 |
| INSMED Inc (INSM) | United States | $26.566B | -26.60 |
| Roivant Sciences Ltd. (ROIV) | $26.105B | -96.08 | |
| BRISTOL MYERS SQUIBB CO (BMY) | United States | $125.637B | 12.67 |
| Royalty Pharma plc (RPRX) | United States | $22.628B | |
| UNITED THERAPEUTICS Corp (UTHR) | United States | $20.249B | 17.64 |
| Viatris Inc (VTRS) | United States | $20.008B | -0.00 |
| VERTEX PHARMACEUTICALS INC / MA (VRTX) | United States | $132.481B | 28.56 |
| Jazz Pharmaceuticals plc (JAZZ) | $15.333B | 16.07 |